Top 5 drugs advertising in professional health journals through March 2015

Print advertising dollars in professional health journals reached over $141 million through March 2015, a nearly 6% decrease year-over-year, according to Kantar Media.

Of the top ten products being advertised in professional health journals through March 2015, only three were on the list at this time in 2014.

Top 5 Print Ad Drugs (Dollars): YTD March 2015
  1. Invokana – $2.94 MM (-49%)
  2. Trulicity – $2.80 MM (N/A)
  3. Xarelto Tablets – $1.82 MM (-15%)
  4. Keytruda for Injection – $1.49 MM (N/A)
  5. Harvoni NB – $1.41 MM (N/A)

The percentage changes compare January–March 2015 to January–March 2014. For more information on these ad insights or other data, let us know.

Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in professional healthcare. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.

Search article